Abstract
CD44 is a transmembrane glycoprotein, which can exist in a multitude of isoforms due to alternative splicing of the pre-mRNA. We have generated monoclonal antibodies to several of these variant regions, which are encoded by 10 additional exons in the extracellular part of the molecule. CD44 variant isoforms have been reported to be involved in the malignant progression of rat and human tumours. The precise localization of CD44 variant isoforms in normal developmental and morphogenetic processes is essential for diagnostic studies of human tumorigenesis. Therefore, we have analysed a large number of different human tissues by immunohistochemistry for the expression of CD44 isoforms containing either exons 4v, 6v or 9v. Expression of exon 9v-isoforms was detected in almost all epithelia analysed, with a few exceptions. Exon 6v isoforms are expressed only in squamous and glandular epithelia, e.g. skin epidermis, sweat and sebaceous glands, oesophagus, ducts of the mammary gland, salivary and prostate glands. Detection of exon 4v-encoded isoforms was restricted to the epidermis and the oesophagus. Similar tissue distributions of CD44 variant isoforms were observed in 10-week-old fetal tissues. Since one of the ligands of CD44 is hyaluronic acid (HA), we also analysed the tissue distribution of HA synthetase. HA synthetase was detected in all tissues analysed, showing good correlation with the expression of the standard form of CD44, CD44s.
Similar content being viewed by others
References
Alho AM, Underhill CB (1989) The hyaluronate receptor is preferentially expressed on proliferating epithelial cells. J Cell Biol 108:1557–1565
Banerjee SD, Toole BP (1992) Hyaluronan-binding protein in endothelial cell morphogenesis. J Cell Biol 119:643–652
Cordell JL, Falini B, Erber WN, Gosh AK, Abdulaziz Z, Macdonald S, Pulford KAF, Stein H, Mason DY (1984) Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem 32:219–229
Fox SB, Gatter KC, Jackson DG, Screaton GR, Bell MV, Bell JI, Harris AL, Simmons D, Fawcett J (1993) CD44 and cancer screening. Lancet 342:548–549
Green SJ, Tarone G, Underhill CB (1988) Distribution of hyaluronate and hyaluronate receptors in the adult lung. J Cell Sci 89:145–156
Günthert U (1993) CD44: a multitude of isoforms with diverse functions. Curr Top Microbiol Immunol 184:47–63
Günthert U, Hofmann M, Rudy W, Reber S, Zöller M, Haussmann I, Matzku S, Wenzel A, Ponta H, Herrlich P (1991) A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 65:13–24
Haynes BF, Telen MJ, Hale LP, Denning SM (1989) CD44-a molecule involved in leukocyte adherence and T-cell activation. Immunol Today 10:423–428
Haynes BF, Liao H-X, Patton KL (1991) The transmembrane hyaluronate receptor (CD44): multiple functions, multiple forms. Cancer Cells 3:347–350
Heider K-H, Dämmrich J, Skroch-Angel P, Müller-Hermelink H-K, Vollmers HP, Herrlich P, Ponta H (1993a) Differential expression of CD44 splice variants in intestinal- and diffuse-type human gastric carcinomas and normal gastric mucosa. Cancer Res 53:4197–4203
Heider K-H, Hofmann M, Horst E, Berg F van den, Ponta H, Herrlich P, Pals ST (1993b) A human homologue of the rat metastasis-associated variant of CD44 is expressed in colorectal carcinomas and adenomatous polyps. J Cell Biol 120:227–233
Hofmann M, Rudy W, Zöller M, Tölg C, Ponta H, Herrlich P, Günthert U (1991) CD44 splice variants confer metastatic behavior in rats: homologous sequences are expressed in human tumor cell lines. Cancer Res 51:5292–5297
Jalkanen S, Jalkanen M (1992) Lymphocyte CD44 binds the COOH-terminal heparing-binding domain of fibronectin. J Cell Biol 116:817–825
Klewes L, Turley EA, Prehm P (1993) The hyualuronate synthase from a eukaryotic cell line. Biochem J 290:791–795
Koopman G, Heider K-H, Horst E, Adolf GR, Berg F van den, Ponta H, Herrlich P, Pals ST (1993) Activated human lymphocytes and aggressive non-Hodgkin's lymphomas express a homologue of the rat metastasis-associated variant of CD44. J Exp Med 177:897–904
Lesley J, Hyman R, Kincade PW (1993) CD44 and its interaction with the extracellular matrix. Adv Immunol 54:271–335
Mackay CR, Maddox JF, Wijffels GL, Mackay IR, Walker ID (1988) Characterization of a 95,000 kD molecule on sheep leucocytes homologous to murine Pgp-1 and human CD44. Immunology 65:93–99
Mackay CR, Terpe H-J, Stauder R, Marston WL, Stark H, Günthert U (1994) Expression and modulation of CD44 variant isoforms in humans. J Cell Biol 124:71–82
Matsumura Y, Tarin D (1992) Significance of CD44 gene products for cancer diagnosis and disease evaluation. Lancet 340:1053–1058
Mayer B, Jauch KW, Günthert U, Figdor CG, Schildberg FW, Funke I, Johnson JP (1993) De-novo expression of CD44 and survival in gastric cancer. Lancet 342:1019–1022
Picker LJ, Nakache M, Butcher EC (1989) Monoclonal antibodies to human lymphocyte homing receptors define a novel class of adhesion molecules on diverse cell types. J Cell Biol 109:927–937
Prehm P (1989) Identification and regulation of the eukaryotic hyaluronate synthase. Ciba Found Symp 143:21–40
Reber S, Matzku S, Günthert U, Ponta H, Herrlich P, Zöller M (1990) Retardation of metastatic tumor growth after immunization with metastasis-specific monoclonal antibodies. Int J Cancer 46:919–927
Rudy W, Hofmann M, Schwartz-Albiez R, Zöller M, Heider K-H, Ponta H, Herrlich P (1993) The two major CD44 proteins expressed on a metastatic rat tumor cell line are derived from different splice variants: each one individually suffices to confer metastatic behavior. Cancer Res 53:1262–1268
Screaton GR, Bell MV, Jackson DG, Cornelis FB, Gerth U, Bell JI (1992) Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc Natl Acad Sci USA 89:12160–12164
Screaton GR, Bell MV, Bell JI, Jackson DG (1993) The identification of a new alternative exon with highly restricted tissue expression in transcripts encoding the mouse Pgp-1 (CD44) homing receptor. Comparison of all 10 variable exons between mouse, human, and rat. J Biol Chem 268:12235–12238
Seiter S, Arch R, Reber S, Komitowski D, Hofmann M, Ponta H, Herrlich P, Matzku S, Zöller M (1993) Prevention of tumor metastasis formation by anti-variant CD44. J Exp Med 177:443–455
Stamenkovic I, Aruffo A, Amiot M, Seed B (1991) The hematopoietic and epithelial forms of CD44 are distinct polypeptides with different adhesion potentials for hyaluronate-bearing cells. EMBO J 10:343–348
Tanabe KK, Ellis LM, Saya H (1993) Expression of CD44R1 adhesion molecule in colon carcinomas and metastases. Lancet 341:725–726
Turley EA, Austen L, Moore D, Hoare K (1993) Ras-transformed cells express both CD44 and RHAMM hyaluronan receptors: only RHAMM is essential for hyaluronan-promoted locomotion. Exp Cell Res 207:277–282
Underhill C (1992) CD44: the hyaluronan receptor. J Cell Sci 103:293–298
Wang C, Tammi M, Tammi R (1992) Distribution of hyaluronan and its CD44 receptor in the epithelia of human skin appendages. Histochemistry 98:105–112
Wielenga VJM, Heider K-H, Offerhaus JA, Adolf GR, Berg FM van den, Ponta H, Herrlich P, Pals ST (1993) Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression. Cancer Res 53:4754–4756
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Terpe, HJ., Stark, H., Prehm, P. et al. CD44 variant isoforms are preferentially expressed in basal epithelia of non-malignant human fetal and adult tissues. Histochemistry 101, 79–89 (1994). https://doi.org/10.1007/BF00269353
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00269353